These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay. Crossey MJ, Dasgupta A. Ther Drug Monit; 1997 Apr; 19(2):185-90. PubMed ID: 9108648 [Abstract] [Full Text] [Related]
16. Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment. Banner W, Bach P, Burk B, Freestone S, Gooch WM. J Toxicol Clin Toxicol; 1992 Apr; 30(2):259-67. PubMed ID: 1588675 [Abstract] [Full Text] [Related]
17. Neutralization of free digoxin-like immunoreactive components of oriental medicines Dan Shen and Lu-Shen-Wan by the Fab fragment of antidigoxin antibody (Digibind). Dasgupta A, Szelei-Stevens KA. Am J Clin Pathol; 2004 Feb; 121(2):276-81. PubMed ID: 14983943 [Abstract] [Full Text] [Related]
19. Analytic performance of two automated nonpretreatment digoxin immunoassays. De BK, Booth DD, Magee PJ, Moore ML, Preuss TM, Rose TA, Roberts WL. Ther Drug Monit; 1999 Feb; 21(1):123-8. PubMed ID: 10051065 [Abstract] [Full Text] [Related]
20. [Treatment of severe digoxin intoxication with antidote]. Houlberg E, Blicher TM. Ugeskr Laeger; 2008 Oct 13; 170(42):3339. PubMed ID: 18940174 [Abstract] [Full Text] [Related] Page: [Next] [New Search]